000			02056 a2200589 4500
005			20250518021916.0
264		0	_c20200402
008			202004s 0 0 eng d
022			_a1532-2807
024	7		_a10.1007/s12253-019-00607-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aVarga, Gergely
245	0	0	_aReal World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program. _h[electronic resource]
260			_bPathology oncology research : POR _cOct 2019
300			_a1615-1620 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBoron Compounds _xadministration & dosage
650	0	4	_aDexamethasone _xadministration & dosage
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGlycine _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aHungary
650	0	4	_aLenalidomide _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aPrognosis
650	0	4	_aRetrospective Studies
650	0	4	_aSafety
650	0	4	_aSalvage Therapy
650	0	4	_aSurvival Rate
700	1		_aNagy, Zsolt
700	1		_aDemeter, Judit
700	1		_aKosztolányi, Szabolcs
700	1		_aSzomor, Árpád
700	1		_aAlizadeh, Hussain
700	1		_aDeák, Beáta
700	1		_aSchneider, Tamás
700	1		_aPlander, Márk
700	1		_aSzendrei, Tamás
700	1		_aVáróczy, László
700	1		_aIllés, Árpád
700	1		_aBátai, Árpád
700	1		_aPető, Mónika
700	1		_aMikala, Gábor
773	0		_tPathology oncology research : POR _gvol. 25 _gno. 4 _gp. 1615-1620
856	4	0	_uhttps://doi.org/10.1007/s12253-019-00607-2 _zAvailable from publisher's website
999			_c29321940 _d29321940